Autophagy in kidney transplants of sirolimus treated recipients

BACKGROUND: Mammalian target of rapamycin (mTOR) inhibitors are increasingly used as immunosuppressive agents in kidney transplantation. In the experimental setting it has been shown that mTOR inhibitors promote autophagy, but the concept that this might also occur in transplant patients has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhayana, Sagar, Baisantry, Arpita, Kraemer, Thomas D., Wrede, Christoph, Hegermann, Jan, Bräsen, Jan-Hinrich, Bockmeyer, Clemens, Ulrich Becker, Jan, Ochs, Matthias, Gwinner, Wilfried, Haller, Hermann, Melk, Anette, Schmitt, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Diabetic Nephropathy Prevention 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418076/
https://www.ncbi.nlm.nih.gov/pubmed/28491859
http://dx.doi.org/10.15171/jnp.2017.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418076/
https://www.ncbi.nlm.nih.gov/pubmed/28491859
http://dx.doi.org/10.15171/jnp.2017.15

Ejemplares similares